8-KItem 2.02 · Results of OperationsItem 7.01 · Reg FD DisclosureItem 8.01 · Other EventsItem 9.01 · Financial Statements

HCA Board authorized an additional $10B share repurchase program (announced Jan 27, 2026).

Filed with the SEC on January 27, 2026 · Summarized by InvestorsBot

HCA Board authorized an additional $10B share repurchase program (announced Jan 27, 2026). Repurchases may be executed in the open market, via privately negotiated transactions, or otherwise. $HCA 💵 #Buyback #Healthcare

HCA declared a quarterly cash dividend of $0.78/share (announced Jan 27, 2026). Payable Mar 31, 2026 to stockholders of record at close on Mar 17, 2026. $HCA 🧾📅 #Dividend #IncomeInvesting

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from HCA Healthcare, Inc.

HCA reports higher second-quarter earnings, lowers 2026 guidance, declares dividend

8-K · July 24, 2026

HCA Healthcare reports higher second-quarter revenue and lowers 2026 guidance

8-K · July 24, 2026

HCA reports higher second-quarter earnings but lowers 2026 guidance

8-K · July 24, 2026

HCA filed an 8‑K on Feb 25, 2026 disclosing Exhibit 10.1 — "HCA Healthcare, Inc.

8-K · February 25, 2026

HCA filed Form 8‑K (Item 9.01) on Jan 27, 2026 — added Exhibit 99.1 (press release dated Jan 27, 2026) and…

8-K · January 27, 2026